Search Within

Maria Michelle Rubinstein

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (3)
Groups
  1. Department of Medicine (7)
  2. GDMT, Medicine (7)
  3. GSK Faculty (7)
  4. Graduate Medical Education (7)
  5. Gynecologic Medicine Service (7)
  6. Gynecology Disease Management Team (7)

More Groups

People
  1. Vicky Makker (7)
  2. Britta Weigelt (6)
  3. Carol Aghajanian (6)
  4. Lora Ellenson (5)
  5. Rachel Grisham (5)
  6. Angela Green (4)

More People

Years
  1. 2025 (2)
  2. 2024 (2)
  3. 2023 (3)
Publications
  1. Gynecologic Oncology (2)
  2. Clinical Cancer Research (1)
  3. International Journal of Gynecological Cancer (1)
  4. JNCI: Journal of the National Cancer Institute (1)
  5. Journal for ImmunoTherapy of Cancer (1)
  6. Journal of Clinical Oncology (1)
Publishers
  1. Elsevier Inc. (2)
  2. American Association for Cancer Research (1)
  3. American Society of Clinical Oncology (1)
  4. Biomed Central Ltd (1)
  5. Lippincott Williams & Wilkins (1)
  6. Oxford University Press (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of rucaparib and nivolumab in patients with leiomyosarcoma
    Journal Article

    Movva, S.; Seier, K.; Bradic, M.; Charalambous, K.; Rosenbaum, E.; Kelly, C. M.; Cohen, S. M.; Hensley, M. L.; Avutu, V.; Banks, L. B.; more...
    Journal for ImmunoTherapy of Cancer (2025)

    Fulltext@MSK | Save
  • A phase II study of fulvestrant plus abemaciclib in hormone receptor–positive advanced or recurrent endometrial cancer
    Journal Article

    Green, A. K.; Zhou, Q.; Iasonos, A.; Zammarrelli, W. A. 3rd; Weigelt, B.; Ellenson, L. H.; Chhetri-Long, R.; Shah, P.; Loh, J.; Hom, V.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Efficacy and safety profile of mirvetuximab in folate receptor alpha-positive ovarian cancer
    Meeting Abstract

    Johannet, P.; Foote, M.; Cohen, S.; Friedman, C.; Green, A.; Guo, R.; Hensley, M.; Konner, J.; Kyi, C.; Liu, Y.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • A phase II study of fulvestrant and abemaciclib in hormone receptor positive advanced or recurrent endometrial cancer
    Meeting Abstract

    Green, A.; Zhou, Q.; Iasonos, A.; Zammarrelli, W.; Weigelt, B.; Ellenson, L. H.; Chhetri-Long, R.; Shah, P.; Hom, V.; Erinjeri, J. P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Germline drivers of gynecologic carcinosarcoma
    Meeting Abstract

    Sia, T.; Birsoy, O.; Kemel, Y.; Maio, A.; Salo-Mullen, E.; Sheehan, M.; Hensley, M.; Rubinstein, M.; Makker, V.; Grisham, R.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Comprehensive analysis of germline drivers in endometrial cancer
    Journal Article

    Gordhandas, S.; Rios-Doria, E.; Cadoo, K. A.; Catchings, A.; Maio, A.; Kemel, Y.; Sheehan, M.; Ranganathan, M.; Green, D.; Aryamvally, A.; more...
    JNCI: Journal of the National Cancer Institute (2023)

    Fulltext@MSK | Save
  • Germline drivers of gynecologic carcinosarcomas
    Journal Article

    Sia, T. Y.; Gordhandas, S. B.; Birsoy, O.; Kemel, Y.; Maio, A.; Salo-Mullen, E.; Sheehan, M.; Hensley, M. L.; Rubinstein, M.; Makker, V.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save